Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

RNAC

Cartesian Therapeutics (RNAC)

Cartesian Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RNAC
DateTimeSourceHeadlineSymbolCompany
06/06/20246:05AMGlobeNewswire Inc.Cartesian Therapeutics Announces New Employment Inducement GrantNASDAQ:RNACCartesian Therapeutics Inc
05/22/20246:00AMGlobeNewswire Inc.Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia GravisNASDAQ:RNACCartesian Therapeutics Inc
05/13/20243:30PMGlobeNewswire Inc.Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQNASDAQ:RNACCartesian Therapeutics Inc
05/08/20246:00AMGlobeNewswire Inc.Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:RNACCartesian Therapeutics Inc
05/06/20243:15PMBusiness WireCartesian Therapeutics Announces New Employment Inducement GrantsNASDAQ:RNACCartesian Therapeutics Inc
04/22/20243:30PMBusiness WireCartesian Therapeutics to Present at the ASGCT 27th Annual MeetingNASDAQ:RNACCartesian Therapeutics Inc
04/04/20246:30AMBusiness WireCartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:RNACCartesian Therapeutics Inc
04/04/20246:00AMBusiness WireCartesian Therapeutics Announces New Employment Inducement GrantsNASDAQ:RNACCartesian Therapeutics Inc
03/28/20243:05PMGlobeNewswire Inc.Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock SplitNASDAQ:RNACCartesian Therapeutics Inc
03/07/20246:00AMGlobeNewswire Inc.Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:RNACCartesian Therapeutics Inc
03/06/20246:00AMGlobeNewswire Inc.Cartesian Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:RNACCartesian Therapeutics Inc
03/05/20246:05AMGlobeNewswire Inc.Cartesian Therapeutics Announces New Employment Inducement GrantNASDAQ:RNACCartesian Therapeutics Inc
03/05/20246:00AMGlobeNewswire Inc.Cartesian Therapeutics Establishes New Corporate Headquarters and State-of-the-Art mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, MarylandNASDAQ:RNACCartesian Therapeutics Inc
02/05/20243:05PMGlobeNewswire Inc.Cartesian Therapeutics Announces New Employment Inducement GrantsNASDAQ:RNACCartesian Therapeutics Inc
01/08/20246:10AMGlobeNewswire Inc.Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for AutoimmunityNASDAQ:RNACCartesian Therapeutics Inc
01/08/20246:00AMGlobeNewswire Inc.Cartesian Therapeutics Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia GravisNASDAQ:RNACCartesian Therapeutics Inc
11/13/20237:05AMGlobeNewswire Inc.Selecta Biosciences Announces Merger with Cartesian TherapeuticsNASDAQ:RNACCartesian Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:RNAC